Issued Patents All Time
Showing 26–50 of 81 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10202412 | β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections | Adel Moussa | 2019-02-12 |
| 10005811 | β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2018-06-26 |
| 10000523 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2018-06-19 |
| 9968628 | Methods and compositions for treating flaviviruses and pestiviruses | Paolo LaColla | 2018-05-15 |
| 9828410 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2017-11-28 |
| 9249173 | Compounds and pharmaceutical compositions for the treatment of viral infections | Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes | 2016-02-02 |
| 8691788 | Compounds and pharmaceutical compositions for the treatment of viral infections | Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes | 2014-04-08 |
| 8674085 | 2′-branched nucleosides and Flaviviridae mutation | Paolo LaColla, David Standring, Vadim Bichko, Lin Qu | 2014-03-18 |
| 8637475 | Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infections | Richard Storer, Gilles Gosselin | 2014-01-28 |
| 8343937 | Methods and compositions for treating flaviviruses and pestiviruses | Paulo LaColla | 2013-01-01 |
| 8299038 | Methods and compositions for treating hepatitis C virus | Paulo LaColla | 2012-10-30 |
| 8158606 | β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies | David Standring, April L. Patty, Maria Seifer | 2012-04-17 |
| 7951789 | Compounds and pharmaceutical compositions for the treatment of viral infections | Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes | 2011-05-31 |
| 7928086 | β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies | David Standring, April L. Patty, Maria Seifer | 2011-04-19 |
| 7902202 | Compounds and pharmaceutical compositions for the treatment of viral infections | Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes | 2011-03-08 |
| 7824851 | 2′-branched nucleosides and Flaviviridae mutation | Paolo LaColla, David Standring, Vadim Bichko, Lin Qu | 2010-11-02 |
| 7662798 | 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Paola LaColla, Gilles Gosselin | 2010-02-16 |
| 7635689 | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Paola LaColla, Richard Storer, Gilles Gosselin | 2009-12-22 |
| 7625875 | 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Gilles Gosselin, Richard Storer, Paola LaColla | 2009-12-01 |
| 7608600 | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Richard Storer, Gilles Gosselin, Paola LaColla | 2009-10-27 |
| 7608597 | Methods and compositions for treating hepatitis C virus | Paulo LaColla | 2009-10-27 |
| 7582618 | 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | Paolo LaColla, Gilles Gosselin | 2009-09-01 |
| 7547704 | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Paola LaColla, Richard Storer, Gilles Gosselin | 2009-06-16 |
| 7468357 | Nucleosides with anti-hepatitis B virus activity | Raymond F. Schinazi, Gilles Gosselin, Jean-Louis Imbach | 2008-12-23 |
| 7456155 | 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | Paolo LaColla, Gilles Gosselin | 2008-11-25 |